The Sonia Elijah Podcast · Investigative journalism, forensic style

New Landmark Study Exposes Fetal Loss Safety Signal Post-Pfizer Covid Shot

·41 min·3 clips
Josh Getzko opens by grounding his perspective in sociology, law, and public health policy. He says that background shaped how he approached the COVID period and the public-health implications of COVID measures and vaccines. The host returns to earlier work on process one and process two with the Pfizer vaccine before moving into the new paper. Getzko says the basic findings came together in about six months. He says the rest of the time went into checking, testing, and adding more material. The discussion centers on a fetal-loss signal analysis after Pfizer COVID vaccination. The paper looks at fetal loss by week of vaccination. The analysis begins at week eight. Getzko says the gap between observed and expected fetal losses is more than four in the early weeks. He says the average across weeks eight through thirteen is about four. He adds that the gap is even higher in some of the earlier weeks. The numbers then drop later in the first trimester. At that point the observed count is a little lower than expected. Getzko treats that as a healthy vaccinee effect rather than a protective effect. He says the influenza results help show why. The influenza pattern is flipped. Among women vaccinated for influenza, the observed eventual fetal losses are much lower than expected across the same period. He says that points to a healthy vaccinee effect rather than a true protective effect. Using influenza as the baseline changes the reading of the COVID-vaccine numbers. Instead of four additional fetal losses in the first trimester, the comparison points to about nine more. The host reacts to that difference as a large one. The conversation keeps coming back to how the counts are defined. Getzko emphasizes that the vaccinated week is not the week of fetal loss. He explains that it is the week of vaccination, with eventual pregnancy loss tracked afterward. The episode then broadens into a criticism of the public-health response. The host cites the later release of safety-signal work and says the public was not told in time. Getzko and the host frame that as a failure by public-health authorities. The episode ends by returning to the value of researchers who push the evidence into public view.

As heard by us

A careful, evidence-led look at a difficult statistical claim.

This episode tracks Josh Getzko as he walks through a paper on fetal-loss counts after Pfizer COVID vaccination, and the strength is in how the case unfolds piece by piece.

Read the full review in PlayNext →

Why you'd press play

You want the data question, not the slogan.

Read the full recommendation in PlayNext →
Listen to the show on